Sports

Traders Change Prices for Cheltenham After Latest Action

Published

5 years ago

February 13, 2020

The Cheltenham Festival, slated to take place from Tuesday, March 10 to Friday, March 13, is one of the most eagerly awaited horse racing events on the National Hunt racing calendar in the UK. Each day will feature 7 races, with the first starting at 1.30pm GMT, and the last race taking place at 5.30pm GMT.

Punters closely monitoring the racers in the next few weeks and are set to bet on Cheltenham guide bookies the world over. And based on the latest race results traders are scrambling to change their prices on the favorites for the Cheltenham Festival.

The Gold Cup

This race is jump-racing’s Blue Riband, and it the finale for the Cheltenham Festival. Slated to take place on Friday, March 13, this Grade 1 racecourse is 3 miles and 2/5 furlongs long and has 22 fences that need to be jumped.

With a prize of £625,000, the Gold Cup is the most valuable non-handicap race in the UK, and only the best horses run this course. This year, there are about 28 potential runners, of which, Al Boum Photo is the big favorite, with odds at 7/2 to win the race. Santini has a 5/1 odds of winning the race, Delta Work has a 6/1 chance and Lostintranslation and Kemboy have 7/1 chances of winning.

However, the one horse that everyone has their eye on this year is Native River. According to the report by SportingLife, Native River won the Betfair Denman Chase at Newbury on Saturday, February 8.

Native River’s ranking before Saturday was at 14/1, but after the race, his odds went up to 12/1 for winning the Gold Cup at Cheltenham.

The Queen Mother Champion Chase

The Queen Mother Champion Chase is the National Hunt’s top minimum-distance chase, and is the main event of Day 2 at the Cheltenham Festival. Slated to take place at 3.30pm on Wednesday on March 11, this race will be run on the Old Course, which is about 2 miles long, and has 13 fences.

The Guardian reported on Altior’s last race, where he won the Game Spirit Chase at Newbury. Altior is expected to race in the Queen Mother Championship Chase at the Cheltenham Festival.

Ridden by jockey Nico de Boinville, and trained by Nicky Henderson, Altior has already won the Queen Mother Championship twice before, and now the odds on him have gone up; he is now at 2/1 joint favorite, along with Defi Du Seuil, to win it again this year. The racer’s previous odds were 3/1.

Cancun Pour Soi will currently be running with odds of 5/2, Cyrname with odds of 8/1, A Plus Tard at odds of 8/1, Cilaos Emery and Min at odds of 10/1, Politologue has odds of 20/1, and Sceau Royal and Dynamite Dollars have odds of 25/1 to win the Chase.

The Brown Advisory Handicap Chase

For this Grade 3 race, Clondaw Castle, who won at the races comfortably on Saturday at Warwick, has finally caught the eyes of punters and traders. Expected to run at the Brown Advisory Handicap Chase at the Cheltenham Festival, Clondaw Castle is now a new favorite, and his rating has been cut from 25/1 to 16/1 to win the race.

The Mares Hurdle

The favorite for the Mares Hurdle at Cheltenham, Indefatigable, has a current rating of 12/1 after she won her race at Warwick by a massive 6 lengths on Saturday.

Another surprise jump in ratings goes to Rouge Vif, whose odds to win the Arkle Change have gone up from 33/1 to 20/1 after he won the Agetur UK Kingmaker Novices’ Chase on Saturday, February 8, at Warwick. The 6-year old horse won his race by an easy 7 lengths.

The Pertemps Final

One For The Team won his Newbury race, and traders set his odds at 14/1 to win the Pertemps Final at Cheltenham. This will be One For The Team’s first showing at the Festival, so this horse, trained by Nick Williams and ridden by Chester Williams will be one to watch at the big races in March.

Ballymore Novices Hudle and Supreme Novices Hurdle

Chantry House, trained by Henderson and ridden by Barry Geraghty, won the 2-mile long Betfair Exchange Novice Hurdle in Newbury on Saturday. This 6-year old had made his debut at Cheltenham, and this was his second victory, keeping his record unbroken. Thanks to his victory at Newbury, Chantry House’s odds have jumped up from 20/1 to 10/1 for winning the Ballymore Novices Hurdle at Cheltenham this year.

Chantry House’s chances to win the Supreme Novices Hurdle at Cheltenham have also gone up to 10/1 after this good performance in the last races.

The one name that is on everyone’s lips for winning the Ballymore Novices Hurdles is Envoi Allen. His odds are stacked at 5/4 to win this race.

Sports

Professional basketball player Kévin Noulowe is close to finalizing a million-dollar sponsorship deal with the Bioscience Stem Cell Institute of Dubai

Published

1 month ago

February 27, 2025

Jonathan Grilli

Kévin Noulowe, a 6’10” professional basketball player, is close to finalizing a million-dollar sponsorship deal with the Bioscience Stem Cell Institute of Dubai, a partnership that could redefine the way athletes and individuals suffering from chronic pain approach healing and recovery.

The star basketball player is known for his athleticism, strength, and dominance on the court but is also known for having to battle injuries throughout his career. Noulowe is turning his attention to regenerative medicine, advocating for stem cell therapy as a breakthrough alternative to invasive surgeries and prolonged rehabilitation. With his towering presence in the sports world, Noulowe aims to bring awareness to the transformative potential of stem cell treatments, particularly for athletes, aging individuals, and those struggling with debilitating conditions.

Stem cell therapy, a rapidly advancing field of regenerative medicine, has gained attention for its ability to repair damaged tissues, accelerate healing, and reduce inflammation without the risks and downtime associated with traditional surgeries. Noulowe, who has seen firsthand how injuries can impact a player’s career, believes this treatment could offer a game-changing solution for athletes looking to recover faster and stay in peak condition.

Beyond the world of sports, Noulowe envisions a broader impact. His partnership with the Dubai-based stem cell institute is driven by a mission to help people across all walks of life—newborns, women, the elderly, and those suffering from chronic pain—access cutting-edge medical advancements that have the potential to restore mobility and improve quality of life.

The deal, while not yet officially signed, is in its final stages, with both parties working toward an agreement that will see Noulowe leverage his platform to promote stem cell awareness on a global scale. His advocacy comes at a time when regenerative medicine is gaining traction as a viable alternative to conventional treatments, with research showing promising results in pain management, injury recovery, and long-term health improvement.

For professional athletes, the implications are significant. Instead of relying on surgeries that can sideline careers and come with long-term consequences, players could turn to regenerative treatments that offer quicker recovery and potentially longer playing careers. Noulowe sees this as an opportunity to introduce a new era in sports medicine, where cutting-edge treatments replace outdated methods of rehabilitation.

While the details of the partnership are still being finalized, Noulowe remains committed to raising awareness and making regenerative medicine more accessible. His vision extends beyond basketball, as he seeks to create a lasting impact on how people worldwide approach healing and recovery.

As discussions near completion, anticipation is growing around what this collaboration could mean for the future of stem cell therapy in both the medical and athletic communities. Noulowe’s influence, combined with scientific advancements in regenerative medicine, has the potential to change the way injuries and chronic pain are treated—ushering in a new frontier of healing.